Tenderwize
Retour à la recherche

Open-House Rabatt Contracts for Follitropin beta

Techniker Krankenkasse·Hamburg, Germany·Deadline Apr 30, 2027 · 247 days left·Open·Supplies
Inscrivez-vous pour sauvegarderOpen documents
Titre original de l'avis

Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2025-04 - Follitropin beta

52/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesOpen
Pourquoi ce score ?

Opportunité

52 / 100

Complexité

58 / 100

Facteurs de risque

Electronic submission through the portal is not allowed, despite portal-based communication; submission must follow the...

Although entry is possible at any time during the contract period, the notice states that timely submission by the 3rd...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • Supplies contract
  • 1 lot
  • Duration until Apr 2027
  • Conclude pharmaceutical rebate contracts for the active substance Follitropin beta.
  • Provide supplies under an Open-House procedure with standard, non-negotiated terms.
Afficher le résumé complet

This is a German Open-House supply arrangement for pharmaceutical products, specifically Rabattverträge for the active substance Follitropin beta. The contracting buyers are Techniker Krankenkasse as lead buyer, with HEK and hkk as participating buyers. It is not an exclusive contract: all suitable pharmaceutical companies may join during the contract period under uniform terms, with no individual negotiations. The contract runs for up to 24 months from 01.05.2025 and ends no later than 30.04.2027. Electronic submission via the portal is not allowed; contracts must be submitted by email with qualified electronic signature or by post, with details in the participation and contract documents.

Risques

Electronic submission through the portal is not allowed, despite portal-based communication; submission must follow the...

Although entry is possible at any time during the contract period, the notice states that timely submission by the 3rd...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Bidder must be a pharmaceutical entrepreneur within the meaning of Section 4(18) AMG for the offered medicinal products.
  • Bidder must have its seat in Germany, another EU Member State, or another EEA state.
  • Bidder must have a valid marketing authorisation for the relevant medicinal product(s), or otherwise be legally entitled to place them on the market in its own name.

Critères d'attribution

Lot 1

Other criterion: participation and suitability requirements; no numeric weight stated.

Acheteur

Localisation

Hamburg, DEU

Identifiant

992-80116-93

Activité

Health

Lots (1)

LOT-0001

Open-House Rabatt Contracts for Follitropin beta

Open-House supply arrangement for pharmaceutical rebate contracts under Section 130a(8) SGB V for the active ingredient Follitropin beta. Scope is nationwide in Germany. The lot information comes from the structured notice and XML notice.

SuppliesEU fundedElectronic submission

Localisation

DE600, Germany

Durée

Apr 2025 - Apr 2027

Catégorie

Pharmaceutical products

Critères d'attribution

Other criterion: participation and suitability requirements; no numeric weight stated.

Date limite

Deadline Apr 30, 2027

Détails de la procédure

Date de publication
16 Mar 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
171456-2025

Documents (1)

Document de consultation 1

Appels d'offres similaires

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3